Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials.

MLA

Sapankaew, Tunlanut, et al. “Efficacy and Safety of Urate-Lowering Agents in Asymptomatic Hyperuricemia: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.” BMC Nephrology, vol. 23, no. 1, June 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12882-022-02850-3.

APA

Sapankaew, T., Thadanipon, K., Ruenroengbun, N., Chaiyakittisopon, K., Ingsathit, A., Numthavaj, P., Chaiyakunapruk, N., McKay, G., Attia, J., & Thakkinstian, A. (2022). Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials. BMC Nephrology, 23(1), 1–10. https://doi.org/10.1186/s12882-022-02850-3

Chicago

Sapankaew, Tunlanut, Kunlawat Thadanipon, Narisa Ruenroengbun, Kamolpat Chaiyakittisopon, Atiporn Ingsathit, Pawin Numthavaj, Nathorn Chaiyakunapruk, Gareth McKay, John Attia, and Ammarin Thakkinstian. 2022. “Efficacy and Safety of Urate-Lowering Agents in Asymptomatic Hyperuricemia: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.” BMC Nephrology 23 (1): 1–10. doi:10.1186/s12882-022-02850-3.